nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—UGT1A1—Pazopanib—kidney cancer	0.251	0.436	CbGbCtD
Testosterone Propionate—UGT1A1—Erlotinib—kidney cancer	0.179	0.311	CbGbCtD
Testosterone Propionate—UGT1A1—Sorafenib—kidney cancer	0.146	0.253	CbGbCtD
Testosterone Propionate—UGT1A1—urine—kidney cancer	0.0152	0.217	CbGeAlD
Testosterone Propionate—CYP17A1—nephron tubule—kidney cancer	0.00447	0.064	CbGeAlD
Testosterone Propionate—CYP17A1—renal system—kidney cancer	0.00407	0.0581	CbGeAlD
Testosterone Propionate—CYP17A1—kidney—kidney cancer	0.00393	0.0562	CbGeAlD
Testosterone Propionate—CYP17A1—cortex of kidney—kidney cancer	0.00383	0.0547	CbGeAlD
Testosterone Propionate—UGT1A1—renal system—kidney cancer	0.00372	0.0532	CbGeAlD
Testosterone Propionate—CYP17A1—gonad—kidney cancer	0.00365	0.0521	CbGeAlD
Testosterone Propionate—UGT1A1—kidney—kidney cancer	0.00359	0.0514	CbGeAlD
Testosterone Propionate—COMT—nephron tubule—kidney cancer	0.00327	0.0468	CbGeAlD
Testosterone Propionate—COMT—renal system—kidney cancer	0.00297	0.0425	CbGeAlD
Testosterone Propionate—COMT—kidney—kidney cancer	0.00287	0.0411	CbGeAlD
Testosterone Propionate—COMT—cortex of kidney—kidney cancer	0.0028	0.04	CbGeAlD
Testosterone Propionate—COMT—gonad—kidney cancer	0.00267	0.0381	CbGeAlD
Testosterone Propionate—COMT—cardiac atrium—kidney cancer	0.00266	0.0381	CbGeAlD
Testosterone Propionate—AR—renal system—kidney cancer	0.00218	0.0311	CbGeAlD
Testosterone Propionate—AR—kidney—kidney cancer	0.0021	0.0301	CbGeAlD
Testosterone Propionate—AR—cortex of kidney—kidney cancer	0.00205	0.0293	CbGeAlD
Testosterone Propionate—AR—gonad—kidney cancer	0.00195	0.0279	CbGeAlD
Testosterone Propionate—AR—cardiac atrium—kidney cancer	0.00195	0.0279	CbGeAlD
Testosterone Propionate—Hydrocortisone—ANXA1—kidney cancer	0.000968	0.318	CrCbGaD
Testosterone Propionate—Drospirenone—BCHE—kidney cancer	0.000597	0.196	CrCbGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	0.000369	0.00402	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000362	0.00394	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000353	0.00384	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000344	0.00375	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000335	0.00365	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000335	0.00365	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000331	0.0036	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000318	0.00346	CbGpPWpGaD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—MAPK3—kidney cancer	0.000317	0.00345	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTP1—kidney cancer	0.000316	0.00345	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—GSTP1—kidney cancer	0.000309	0.00337	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—CD4—kidney cancer	0.000307	0.00334	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TSC1—kidney cancer	0.000307	0.00334	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ANXA1—kidney cancer	0.000307	0.00334	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTP1—kidney cancer	0.000305	0.00332	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—CDKN1B—kidney cancer	0.000304	0.00331	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000304	0.00117	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000303	0.00117	CcSEcCtD
Testosterone Propionate—Asthenia—Vinblastine—kidney cancer	0.000303	0.00117	CcSEcCtD
Testosterone Propionate—Fatigue—Sunitinib—kidney cancer	0.000303	0.00117	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—ACHE—kidney cancer	0.000303	0.0033	CbGpPWpGaD
Testosterone Propionate—Asthenia—Everolimus—kidney cancer	0.000302	0.00116	CcSEcCtD
Testosterone Propionate—Angiopathy—Paclitaxel—kidney cancer	0.000302	0.00116	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—MAPK1—kidney cancer	0.000301	0.00328	CbGpPWpGaD
Testosterone Propionate—Pain—Sunitinib—kidney cancer	0.000301	0.00116	CcSEcCtD
Testosterone Propionate—Immune system disorder—Paclitaxel—kidney cancer	0.0003	0.00116	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Paclitaxel—kidney cancer	0.0003	0.00116	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Sorafenib—kidney cancer	0.000299	0.00115	CcSEcCtD
Testosterone Propionate—Hypertension—Gemcitabine—kidney cancer	0.000299	0.00115	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—AURKA—kidney cancer	0.000298	0.00325	CbGpPWpGaD
Testosterone Propionate—Pruritus—Everolimus—kidney cancer	0.000298	0.00115	CcSEcCtD
Testosterone Propionate—Oedema—Vincristine—kidney cancer	0.000297	0.00115	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Vincristine—kidney cancer	0.000297	0.00115	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTP1—kidney cancer	0.000296	0.00322	CbGpPWpGaD
Testosterone Propionate—Arthralgia—Gemcitabine—kidney cancer	0.000294	0.00113	CcSEcCtD
Testosterone Propionate—Myalgia—Gemcitabine—kidney cancer	0.000294	0.00113	CcSEcCtD
Testosterone Propionate—Alopecia—Paclitaxel—kidney cancer	0.000294	0.00113	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000292	0.00113	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTP1—kidney cancer	0.000292	0.00318	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Vincristine—kidney cancer	0.000292	0.00112	CcSEcCtD
Testosterone Propionate—Asthenia—Erlotinib—kidney cancer	0.000291	0.00112	CcSEcCtD
Testosterone Propionate—Mental disorder—Paclitaxel—kidney cancer	0.000291	0.00112	CcSEcCtD
Testosterone Propionate—Discomfort—Gemcitabine—kidney cancer	0.000291	0.00112	CcSEcCtD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTM1—kidney cancer	0.000291	0.00317	CbGpPWpGaD
Testosterone Propionate—Urticaria—Sorafenib—kidney cancer	0.00029	0.00112	CcSEcCtD
Testosterone Propionate—Haematuria—Capecitabine—kidney cancer	0.00029	0.00112	CcSEcCtD
Testosterone Propionate—AR—FOXA1 transcription factor network—JUN—kidney cancer	0.00029	0.00315	CbGpPWpGaD
Testosterone Propionate—Malnutrition—Paclitaxel—kidney cancer	0.00029	0.00112	CcSEcCtD
Testosterone Propionate—Diarrhoea—Vinblastine—kidney cancer	0.000289	0.00111	CcSEcCtD
Testosterone Propionate—Abdominal pain—Sorafenib—kidney cancer	0.000289	0.00111	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—CDKN1B—kidney cancer	0.000289	0.00314	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Everolimus—kidney cancer	0.000288	0.00111	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Sunitinib—kidney cancer	0.000288	0.00111	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Capecitabine—kidney cancer	0.000288	0.00111	CcSEcCtD
Testosterone Propionate—Pruritus—Erlotinib—kidney cancer	0.000287	0.00111	CcSEcCtD
Testosterone Propionate—Fatigue—Dactinomycin—kidney cancer	0.000287	0.00111	CcSEcCtD
Testosterone Propionate—Pain—Dactinomycin—kidney cancer	0.000285	0.0011	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—GSTM1—kidney cancer	0.000284	0.00309	CbGpPWpGaD
Testosterone Propionate—Oedema—Gemcitabine—kidney cancer	0.000282	0.00109	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Gemcitabine—kidney cancer	0.000282	0.00109	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTM1—kidney cancer	0.00028	0.00305	CbGpPWpGaD
Testosterone Propionate—Dizziness—Vinblastine—kidney cancer	0.00028	0.00108	CcSEcCtD
Testosterone Propionate—Dizziness—Everolimus—kidney cancer	0.000278	0.00107	CcSEcCtD
Testosterone Propionate—Abdominal pain—Sunitinib—kidney cancer	0.000278	0.00107	CcSEcCtD
Testosterone Propionate—Diarrhoea—Erlotinib—kidney cancer	0.000278	0.00107	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Gemcitabine—kidney cancer	0.000277	0.00107	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000276	0.00301	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—PAK1—kidney cancer	0.000275	0.003	CbGpPWpGaD
Testosterone Propionate—Drospirenone—PTGS2—kidney cancer	0.000275	0.0903	CrCbGaD
Testosterone Propionate—Feeling abnormal—Dactinomycin—kidney cancer	0.000274	0.00106	CcSEcCtD
Testosterone Propionate—Haemoglobin—Capecitabine—kidney cancer	0.000274	0.00106	CcSEcCtD
Testosterone Propionate—Skin disorder—Gemcitabine—kidney cancer	0.000274	0.00106	CcSEcCtD
Testosterone Propionate—Haemorrhage—Capecitabine—kidney cancer	0.000273	0.00105	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000272	0.00105	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTM1—kidney cancer	0.000272	0.00296	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000271	0.00104	CcSEcCtD
Testosterone Propionate—Increased appetite—Doxorubicin—kidney cancer	0.000271	0.00104	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Capecitabine—kidney cancer	0.00027	0.00104	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Sorafenib—kidney cancer	0.000269	0.00104	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—CYP1A1—kidney cancer	0.000269	0.00293	CbGpPWpGaD
Testosterone Propionate—Insomnia—Vincristine—kidney cancer	0.000269	0.00104	CcSEcCtD
Testosterone Propionate—Vomiting—Vinblastine—kidney cancer	0.000269	0.00104	CcSEcCtD
Testosterone Propionate—Dizziness—Erlotinib—kidney cancer	0.000269	0.00104	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Paclitaxel—kidney cancer	0.000269	0.00104	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTM1—kidney cancer	0.000268	0.00292	CbGpPWpGaD
Testosterone Propionate—Connective tissue disorder—Capecitabine—kidney cancer	0.000268	0.00103	CcSEcCtD
Testosterone Propionate—Megestrol acetate—ABCB1—kidney cancer	0.000268	0.0879	CrCbGaD
Testosterone Propionate—Vomiting—Everolimus—kidney cancer	0.000268	0.00103	CcSEcCtD
Testosterone Propionate—Urethral disorder—Capecitabine—kidney cancer	0.000268	0.00103	CcSEcCtD
Testosterone Propionate—Paraesthesia—Vincristine—kidney cancer	0.000267	0.00103	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTT1—kidney cancer	0.000267	0.00291	CbGpPWpGaD
Testosterone Propionate—Dermatitis bullous—Doxorubicin—kidney cancer	0.000266	0.00103	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP1A1—kidney cancer	0.000266	0.00289	CbGpPWpGaD
Testosterone Propionate—Rash—Everolimus—kidney cancer	0.000265	0.00102	CcSEcCtD
Testosterone Propionate—Dermatitis—Everolimus—kidney cancer	0.000265	0.00102	CcSEcCtD
Testosterone Propionate—Headache—Vinblastine—kidney cancer	0.000265	0.00102	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CDKN2A—kidney cancer	0.000265	0.00288	CbGpPWpGaD
Testosterone Propionate—Headache—Everolimus—kidney cancer	0.000264	0.00102	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—BCHE—kidney cancer	0.000264	0.00287	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Dactinomycin—kidney cancer	0.000263	0.00101	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000263	0.00101	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—kidney cancer	0.000262	0.00286	CbGpPWpGaD
Testosterone Propionate—Asthenia—Sorafenib—kidney cancer	0.000262	0.00101	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC5A5—kidney cancer	0.000262	0.00285	CbGpPWpGaD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—PIK3CA—kidney cancer	0.000262	0.00285	CbGpPWpGaD
Testosterone Propionate—Malaise—Paclitaxel—kidney cancer	0.000261	0.00101	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	0.000261	0.00284	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Sunitinib—kidney cancer	0.000259	0.000999	CcSEcCtD
Testosterone Propionate—Pruritus—Sorafenib—kidney cancer	0.000259	0.000997	CcSEcCtD
Testosterone Propionate—Vomiting—Erlotinib—kidney cancer	0.000258	0.000996	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP1A1—kidney cancer	0.000258	0.00281	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000257	0.000991	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Vincristine—kidney cancer	0.000257	0.00099	CcSEcCtD
Testosterone Propionate—Fatigue—Vincristine—kidney cancer	0.000256	0.000988	CcSEcCtD
Testosterone Propionate—Rash—Erlotinib—kidney cancer	0.000256	0.000987	CcSEcCtD
Testosterone Propionate—Dermatitis—Erlotinib—kidney cancer	0.000256	0.000986	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	0.000255	0.00278	CbGpPWpGaD
Testosterone Propionate—Insomnia—Gemcitabine—kidney cancer	0.000255	0.000984	CcSEcCtD
Testosterone Propionate—Headache—Erlotinib—kidney cancer	0.000255	0.000981	CcSEcCtD
Testosterone Propionate—Pain—Vincristine—kidney cancer	0.000254	0.00098	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000254	0.00098	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP1A1—kidney cancer	0.000254	0.00277	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000254	0.00277	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Gemcitabine—kidney cancer	0.000253	0.000977	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC2A1—kidney cancer	0.000253	0.00276	CbGpPWpGaD
Testosterone Propionate—Asthenia—Sunitinib—kidney cancer	0.000252	0.000973	CcSEcCtD
Testosterone Propionate—Dyspnoea—Gemcitabine—kidney cancer	0.000252	0.00097	CcSEcCtD
Testosterone Propionate—Nausea—Vinblastine—kidney cancer	0.000251	0.000968	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000251	0.00273	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—PTGS1—kidney cancer	0.00025	0.00273	CbGpPWpGaD
Testosterone Propionate—Nausea—Everolimus—kidney cancer	0.00025	0.000964	CcSEcCtD
Testosterone Propionate—Diarrhoea—Sorafenib—kidney cancer	0.00025	0.000964	CcSEcCtD
Testosterone Propionate—Hypertension—Paclitaxel—kidney cancer	0.00025	0.000963	CcSEcCtD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—JUN—kidney cancer	0.00025	0.00272	CbGpPWpGaD
Testosterone Propionate—Pruritus—Sunitinib—kidney cancer	0.000249	0.000959	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	0.000248	0.00271	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Capecitabine—kidney cancer	0.000248	0.000954	CcSEcCtD
Testosterone Propionate—Immune system disorder—Capecitabine—kidney cancer	0.000247	0.00095	CcSEcCtD
Testosterone Propionate—Arthralgia—Paclitaxel—kidney cancer	0.000246	0.00095	CcSEcCtD
Testosterone Propionate—Myalgia—Paclitaxel—kidney cancer	0.000246	0.00095	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Capecitabine—kidney cancer	0.000246	0.000948	CcSEcCtD
Testosterone Propionate—Anxiety—Paclitaxel—kidney cancer	0.000246	0.000947	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Dactinomycin—kidney cancer	0.000245	0.000945	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000245	0.000943	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000244	0.000939	CcSEcCtD
Testosterone Propionate—Discomfort—Paclitaxel—kidney cancer	0.000244	0.000939	CcSEcCtD
Testosterone Propionate—Fatigue—Gemcitabine—kidney cancer	0.000243	0.000938	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Vincristine—kidney cancer	0.000243	0.000938	CcSEcCtD
Testosterone Propionate—Dizziness—Sorafenib—kidney cancer	0.000242	0.000932	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—kidney cancer	0.000241	0.00263	CbGpPWpGaD
Testosterone Propionate—Pain—Gemcitabine—kidney cancer	0.000241	0.00093	CcSEcCtD
Testosterone Propionate—Nausea—Erlotinib—kidney cancer	0.000241	0.00093	CcSEcCtD
Testosterone Propionate—Alopecia—Capecitabine—kidney cancer	0.000241	0.000929	CcSEcCtD
Testosterone Propionate—Diarrhoea—Sunitinib—kidney cancer	0.000241	0.000927	CcSEcCtD
Testosterone Propionate—Mental disorder—Capecitabine—kidney cancer	0.000239	0.000922	CcSEcCtD
Testosterone Propionate—Asthenia—Dactinomycin—kidney cancer	0.000239	0.000921	CcSEcCtD
Testosterone Propionate—Confusional state—Paclitaxel—kidney cancer	0.000238	0.000918	CcSEcCtD
Testosterone Propionate—Malnutrition—Capecitabine—kidney cancer	0.000238	0.000916	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—ACY1—kidney cancer	0.000237	0.00258	CbGpPWpGaD
Testosterone Propionate—Anaphylactic shock—Paclitaxel—kidney cancer	0.000236	0.000911	CcSEcCtD
Testosterone Propionate—Oedema—Paclitaxel—kidney cancer	0.000236	0.000911	CcSEcCtD
Testosterone Propionate—Abdominal pain—Vincristine—kidney cancer	0.000235	0.000906	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—EGR1—kidney cancer	0.000235	0.00256	CbGpPWpGaD
Testosterone Propionate—Liver function test abnormal—Doxorubicin—kidney cancer	0.000235	0.000905	CcSEcCtD
Testosterone Propionate—Dizziness—Sunitinib—kidney cancer	0.000233	0.000896	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Gemcitabine—kidney cancer	0.000233	0.000896	CcSEcCtD
Testosterone Propionate—Vomiting—Sorafenib—kidney cancer	0.000232	0.000896	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Paclitaxel—kidney cancer	0.000232	0.000893	CcSEcCtD
Testosterone Propionate—Rash—Sorafenib—kidney cancer	0.00023	0.000888	CcSEcCtD
Testosterone Propionate—Dermatitis—Sorafenib—kidney cancer	0.00023	0.000887	CcSEcCtD
Testosterone Propionate—Breast disorder—Doxorubicin—kidney cancer	0.00023	0.000886	CcSEcCtD
Testosterone Propionate—Skin disorder—Paclitaxel—kidney cancer	0.00023	0.000885	CcSEcCtD
Testosterone Propionate—Headache—Sorafenib—kidney cancer	0.000229	0.000882	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000228	0.00248	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000228	0.00248	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Dactinomycin—kidney cancer	0.000228	0.000878	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—ACY1—kidney cancer	0.000227	0.00247	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BRCA2—kidney cancer	0.000226	0.00246	CbGpPWpGaD
Testosterone Propionate—Vomiting—Sunitinib—kidney cancer	0.000224	0.000862	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CCND1—kidney cancer	0.000224	0.00243	CbGpPWpGaD
Testosterone Propionate—Rash—Sunitinib—kidney cancer	0.000222	0.000855	CcSEcCtD
Testosterone Propionate—Dermatitis—Sunitinib—kidney cancer	0.000222	0.000854	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CTNNB1—kidney cancer	0.000221	0.00241	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Capecitabine—kidney cancer	0.00022	0.00085	CcSEcCtD
Testosterone Propionate—Headache—Sunitinib—kidney cancer	0.00022	0.000849	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Vincristine—kidney cancer	0.000219	0.000845	CcSEcCtD
Testosterone Propionate—Nausea—Sorafenib—kidney cancer	0.000217	0.000837	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000215	0.00083	CcSEcCtD
Testosterone Propionate—Malaise—Capecitabine—kidney cancer	0.000214	0.000826	CcSEcCtD
Testosterone Propionate—Insomnia—Paclitaxel—kidney cancer	0.000214	0.000824	CcSEcCtD
Testosterone Propionate—Asthenia—Vincristine—kidney cancer	0.000213	0.000823	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000213	0.00232	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—kidney cancer	0.000213	0.00232	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Paclitaxel—kidney cancer	0.000212	0.000818	CcSEcCtD
Testosterone Propionate—Vomiting—Dactinomycin—kidney cancer	0.000212	0.000816	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTP1—kidney cancer	0.000211	0.0023	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Paclitaxel—kidney cancer	0.000211	0.000812	CcSEcCtD
Testosterone Propionate—Rash—Dactinomycin—kidney cancer	0.00021	0.000809	CcSEcCtD
Testosterone Propionate—Nausea—Sunitinib—kidney cancer	0.000209	0.000805	CcSEcCtD
Testosterone Propionate—Dysuria—Doxorubicin—kidney cancer	0.000206	0.000792	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—HARS—kidney cancer	0.000205	0.00224	CbGpPWpGaD
Testosterone Propionate—Hypertension—Capecitabine—kidney cancer	0.000205	0.000791	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000204	0.000786	CcSEcCtD
Testosterone Propionate—Fatigue—Paclitaxel—kidney cancer	0.000204	0.000785	CcSEcCtD
Testosterone Propionate—Diarrhoea—Vincristine—kidney cancer	0.000204	0.000784	CcSEcCtD
Testosterone Propionate—Asthenia—Gemcitabine—kidney cancer	0.000202	0.00078	CcSEcCtD
Testosterone Propionate—Myalgia—Capecitabine—kidney cancer	0.000202	0.00078	CcSEcCtD
Testosterone Propionate—Arthralgia—Capecitabine—kidney cancer	0.000202	0.00078	CcSEcCtD
Testosterone Propionate—Pain—Paclitaxel—kidney cancer	0.000202	0.000779	CcSEcCtD
Testosterone Propionate—Anxiety—Capecitabine—kidney cancer	0.000202	0.000777	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—PDHB—kidney cancer	0.000201	0.00219	CbGpPWpGaD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000201	0.000774	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—POMC—kidney cancer	0.000201	0.00219	CbGpPWpGaD
Testosterone Propionate—Weight increased—Doxorubicin—kidney cancer	0.0002	0.000771	CcSEcCtD
Testosterone Propionate—Discomfort—Capecitabine—kidney cancer	0.0002	0.00077	CcSEcCtD
Testosterone Propionate—Pruritus—Gemcitabine—kidney cancer	0.0002	0.00077	CcSEcCtD
Testosterone Propionate—Nausea—Dactinomycin—kidney cancer	0.000198	0.000762	CcSEcCtD
Testosterone Propionate—Dizziness—Vincristine—kidney cancer	0.000197	0.000758	CcSEcCtD
Testosterone Propionate—Confusional state—Capecitabine—kidney cancer	0.000196	0.000754	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Paclitaxel—kidney cancer	0.000195	0.00075	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTM1—kidney cancer	0.000194	0.00211	CbGpPWpGaD
Testosterone Propionate—Oedema—Capecitabine—kidney cancer	0.000194	0.000747	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000193	0.00211	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000193	0.000745	CcSEcCtD
Testosterone Propionate—Diarrhoea—Gemcitabine—kidney cancer	0.000193	0.000744	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—PDHB—kidney cancer	0.000193	0.0021	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—POMC—kidney cancer	0.000192	0.00209	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Capecitabine—kidney cancer	0.00019	0.000733	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—CCBL1—kidney cancer	0.000189	0.00206	CbGpPWpGaD
Testosterone Propionate—Vomiting—Vincristine—kidney cancer	0.000189	0.000729	CcSEcCtD
Testosterone Propionate—Skin disorder—Capecitabine—kidney cancer	0.000188	0.000726	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—RELA—kidney cancer	0.000188	0.00205	CbGpPWpGaD
Testosterone Propionate—Urticaria—Paclitaxel—kidney cancer	0.000188	0.000723	CcSEcCtD
Testosterone Propionate—Rash—Vincristine—kidney cancer	0.000188	0.000723	CcSEcCtD
Testosterone Propionate—Dermatitis—Vincristine—kidney cancer	0.000187	0.000722	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000187	0.00204	CbGpPWpGaD
Testosterone Propionate—Haematuria—Doxorubicin—kidney cancer	0.000187	0.00072	CcSEcCtD
Testosterone Propionate—Abdominal pain—Paclitaxel—kidney cancer	0.000187	0.00072	CcSEcCtD
Testosterone Propionate—Headache—Vincristine—kidney cancer	0.000186	0.000718	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000186	0.00202	CbGpPWpGaD
Testosterone Propionate—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000185	0.000714	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTP1—kidney cancer	0.000185	0.00202	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTP1—kidney cancer	0.000183	0.00199	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000181	0.00198	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CCBL1—kidney cancer	0.000181	0.00197	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—kidney cancer	0.00018	0.00196	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—kidney cancer	0.00018	0.00196	CbGpPWpGaD
Testosterone Propionate—Vomiting—Gemcitabine—kidney cancer	0.000179	0.000692	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TSC2—kidney cancer	0.000179	0.00195	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—kidney cancer	0.000178	0.00194	CbGpPWpGaD
Testosterone Propionate—Rash—Gemcitabine—kidney cancer	0.000178	0.000686	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	0.000178	0.00194	CbGpPWpGaD
Testosterone Propionate—Dermatitis—Gemcitabine—kidney cancer	0.000178	0.000685	CcSEcCtD
Testosterone Propionate—Haemoglobin—Doxorubicin—kidney cancer	0.000177	0.000681	CcSEcCtD
Testosterone Propionate—Headache—Gemcitabine—kidney cancer	0.000177	0.000681	CcSEcCtD
Testosterone Propionate—Nausea—Vincristine—kidney cancer	0.000177	0.000681	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000177	0.000681	CcSEcCtD
Testosterone Propionate—Haemorrhage—Doxorubicin—kidney cancer	0.000176	0.000678	CcSEcCtD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000176	0.00191	CbGpPWpGaD
Testosterone Propionate—Insomnia—Capecitabine—kidney cancer	0.000175	0.000676	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—EIF5B—kidney cancer	0.000175	0.0019	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000175	0.0019	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Capecitabine—kidney cancer	0.000174	0.000671	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Paclitaxel—kidney cancer	0.000174	0.000671	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Doxorubicin—kidney cancer	0.000174	0.00067	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Doxorubicin—kidney cancer	0.000173	0.000666	CcSEcCtD
Testosterone Propionate—Dyspnoea—Capecitabine—kidney cancer	0.000173	0.000666	CcSEcCtD
Testosterone Propionate—Urethral disorder—Doxorubicin—kidney cancer	0.000172	0.000665	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTM1—kidney cancer	0.00017	0.00185	CbGpPWpGaD
Testosterone Propionate—Progesterone—CYP1A1—kidney cancer	0.00017	0.0557	CrCbGaD
Testosterone Propionate—Asthenia—Paclitaxel—kidney cancer	0.00017	0.000653	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTM1—kidney cancer	0.000168	0.00183	CbGpPWpGaD
Testosterone Propionate—Nausea—Gemcitabine—kidney cancer	0.000168	0.000646	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000167	0.000645	CcSEcCtD
Testosterone Propionate—Fatigue—Capecitabine—kidney cancer	0.000167	0.000644	CcSEcCtD
Testosterone Propionate—Pruritus—Paclitaxel—kidney cancer	0.000167	0.000644	CcSEcCtD
Testosterone Propionate—Spironolactone—ABCB1—kidney cancer	0.000167	0.0547	CrCbGaD
Testosterone Propionate—Pain—Capecitabine—kidney cancer	0.000166	0.000639	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CCND1—kidney cancer	0.000165	0.0018	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—JUN—kidney cancer	0.000165	0.0018	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PPAT—kidney cancer	0.000164	0.00179	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GLIPR1—kidney cancer	0.000164	0.00179	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000164	0.00179	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CTNNB1—kidney cancer	0.000164	0.00178	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Paclitaxel—kidney cancer	0.000162	0.000623	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP1A1—kidney cancer	0.000161	0.00176	CbGpPWpGaD
Testosterone Propionate—Testosterone—CYP1A1—kidney cancer	0.00016	0.0526	CrCbGaD
Testosterone Propionate—Feeling abnormal—Capecitabine—kidney cancer	0.00016	0.000616	CcSEcCtD
Testosterone Propionate—Angiopathy—Doxorubicin—kidney cancer	0.00016	0.000615	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—PTEN—kidney cancer	0.000159	0.00174	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP1A1—kidney cancer	0.000159	0.00173	CbGpPWpGaD
Testosterone Propionate—Immune system disorder—Doxorubicin—kidney cancer	0.000159	0.000612	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Capecitabine—kidney cancer	0.000159	0.000611	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Doxorubicin—kidney cancer	0.000159	0.000611	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—PPAT—kidney cancer	0.000157	0.00171	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GLIPR1—kidney cancer	0.000157	0.00171	CbGpPWpGaD
Testosterone Propionate—Dizziness—Paclitaxel—kidney cancer	0.000156	0.000602	CcSEcCtD
Testosterone Propionate—Alopecia—Doxorubicin—kidney cancer	0.000155	0.000599	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000155	0.00169	CbGpPWpGaD
Testosterone Propionate—Norethindrone—ABCB1—kidney cancer	0.000155	0.0508	CrCbGaD
Testosterone Propionate—Mental disorder—Doxorubicin—kidney cancer	0.000154	0.000594	CcSEcCtD
Testosterone Propionate—Urticaria—Capecitabine—kidney cancer	0.000154	0.000594	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000154	0.00167	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Capecitabine—kidney cancer	0.000153	0.000591	CcSEcCtD
Testosterone Propionate—Malnutrition—Doxorubicin—kidney cancer	0.000153	0.00059	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—FH—kidney cancer	0.000153	0.00166	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—APRT—kidney cancer	0.000153	0.00166	CbGpPWpGaD
Testosterone Propionate—Vomiting—Paclitaxel—kidney cancer	0.00015	0.000579	CcSEcCtD
Testosterone Propionate—Rash—Paclitaxel—kidney cancer	0.000149	0.000574	CcSEcCtD
Testosterone Propionate—Dermatitis—Paclitaxel—kidney cancer	0.000149	0.000574	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000148	0.00162	CbGpPWpGaD
Testosterone Propionate—Headache—Paclitaxel—kidney cancer	0.000148	0.00057	CcSEcCtD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000147	0.0016	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—FH—kidney cancer	0.000146	0.00159	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—APRT—kidney cancer	0.000146	0.00159	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.000145	0.00158	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—kidney cancer	0.000144	0.00157	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GPC3—kidney cancer	0.000143	0.00156	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	0.000143	0.00156	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Capecitabine—kidney cancer	0.000143	0.000551	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000143	0.00156	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Doxorubicin—kidney cancer	0.000142	0.000548	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—ACY1—kidney cancer	0.000142	0.00155	CbGpPWpGaD
Testosterone Propionate—Nausea—Paclitaxel—kidney cancer	0.00014	0.000541	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—CA2—kidney cancer	0.00014	0.00152	CbGpPWpGaD
Testosterone Propionate—Asthenia—Capecitabine—kidney cancer	0.000139	0.000536	CcSEcCtD
Testosterone Propionate—Malaise—Doxorubicin—kidney cancer	0.000138	0.000532	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—GPC3—kidney cancer	0.000137	0.0015	CbGpPWpGaD
Testosterone Propionate—Pruritus—Capecitabine—kidney cancer	0.000137	0.000529	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—ALAD—kidney cancer	0.000136	0.00148	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—BRAF—kidney cancer	0.000135	0.00147	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CA2—kidney cancer	0.000134	0.00146	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ST3GAL2—kidney cancer	0.000133	0.00145	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Capecitabine—kidney cancer	0.000133	0.000511	CcSEcCtD
Testosterone Propionate—Hypertension—Doxorubicin—kidney cancer	0.000132	0.00051	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000131	0.00142	CbGpPWpGaD
Testosterone Propionate—Arthralgia—Doxorubicin—kidney cancer	0.00013	0.000502	CcSEcCtD
Testosterone Propionate—Myalgia—Doxorubicin—kidney cancer	0.00013	0.000502	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—ALAD—kidney cancer	0.00013	0.00142	CbGpPWpGaD
Testosterone Propionate—Anxiety—Doxorubicin—kidney cancer	0.00013	0.000501	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—ALDH1A1—kidney cancer	0.00013	0.00141	CbGpPWpGaD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000129	0.000499	CcSEcCtD
Testosterone Propionate—Discomfort—Doxorubicin—kidney cancer	0.000129	0.000496	CcSEcCtD
Testosterone Propionate—Dizziness—Capecitabine—kidney cancer	0.000128	0.000494	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—ST3GAL2—kidney cancer	0.000127	0.00138	CbGpPWpGaD
Testosterone Propionate—Confusional state—Doxorubicin—kidney cancer	0.000126	0.000486	CcSEcCtD
Testosterone Propionate—Oedema—Doxorubicin—kidney cancer	0.000125	0.000482	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Doxorubicin—kidney cancer	0.000125	0.000482	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—SLC5A3—kidney cancer	0.000124	0.00135	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PGK1—kidney cancer	0.000124	0.00135	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ALDH1A1—kidney cancer	0.000124	0.00135	CbGpPWpGaD
Testosterone Propionate—Vomiting—Capecitabine—kidney cancer	0.000123	0.000475	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Doxorubicin—kidney cancer	0.000123	0.000472	CcSEcCtD
Testosterone Propionate—Rash—Capecitabine—kidney cancer	0.000122	0.000471	CcSEcCtD
Testosterone Propionate—Dermatitis—Capecitabine—kidney cancer	0.000122	0.000471	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—LDHB—kidney cancer	0.000122	0.00133	CbGpPWpGaD
Testosterone Propionate—Headache—Capecitabine—kidney cancer	0.000121	0.000468	CcSEcCtD
Testosterone Propionate—Skin disorder—Doxorubicin—kidney cancer	0.000121	0.000468	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.000121	0.00132	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PDHB—kidney cancer	0.000121	0.00131	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—POMC—kidney cancer	0.00012	0.00131	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SLC5A3—kidney cancer	0.000119	0.0013	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PGK1—kidney cancer	0.000119	0.0013	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—LDHB—kidney cancer	0.000117	0.00127	CbGpPWpGaD
Testosterone Propionate—Nausea—Capecitabine—kidney cancer	0.000115	0.000444	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000114	0.000439	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—CCBL1—kidney cancer	0.000113	0.00124	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—JUNB—kidney cancer	0.000113	0.00123	CbGpPWpGaD
Testosterone Propionate—Insomnia—Doxorubicin—kidney cancer	0.000113	0.000436	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—EEF2—kidney cancer	0.000113	0.00123	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—RAF1—kidney cancer	0.000112	0.00122	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Doxorubicin—kidney cancer	0.000112	0.000433	CcSEcCtD
Testosterone Propionate—Dyspnoea—Doxorubicin—kidney cancer	0.000111	0.000429	CcSEcCtD
Testosterone Propionate—Hydrocortisone—ABCB1—kidney cancer	0.000111	0.0363	CrCbGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.000108	0.00118	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.000108	0.00118	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000108	0.000416	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—TET2—kidney cancer	0.000108	0.00117	CbGpPWpGaD
Testosterone Propionate—Fatigue—Doxorubicin—kidney cancer	0.000108	0.000415	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.000107	0.00117	CbGpPWpGaD
Testosterone Propionate—Pain—Doxorubicin—kidney cancer	0.000107	0.000412	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—CA9—kidney cancer	0.000106	0.00115	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000105	0.00115	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000104	0.00114	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000104	0.00114	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Doxorubicin—kidney cancer	0.000103	0.000397	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000103	0.00112	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000102	0.000394	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000102	0.00111	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CA9—kidney cancer	0.000101	0.0011	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000101	0.0011	CbGpPWpGaD
Testosterone Propionate—Urticaria—Doxorubicin—kidney cancer	9.93e-05	0.000383	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	9.93e-05	0.00108	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.9e-05	0.00108	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Doxorubicin—kidney cancer	9.88e-05	0.000381	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—TCEB2—kidney cancer	9.87e-05	0.00107	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—TCEB1—kidney cancer	9.87e-05	0.00107	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GLIPR1—kidney cancer	9.83e-05	0.00107	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PPAT—kidney cancer	9.83e-05	0.00107	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	9.44e-05	0.00103	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	9.4e-05	0.00102	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—CDKN2B—kidney cancer	9.22e-05	0.001	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Doxorubicin—kidney cancer	9.21e-05	0.000355	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—VEGFA—kidney cancer	9.19e-05	0.001	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—APRT—kidney cancer	9.14e-05	0.000996	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—FH—kidney cancer	9.14e-05	0.000996	CbGpPWpGaD
Testosterone Propionate—Progesterone—ABCB1—kidney cancer	9.01e-05	0.0296	CrCbGaD
Testosterone Propionate—COMT—Metabolism—CRABP1—kidney cancer	8.99e-05	0.000979	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	8.97e-05	0.000977	CbGpPWpGaD
Testosterone Propionate—Asthenia—Doxorubicin—kidney cancer	8.97e-05	0.000346	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	8.95e-05	0.000975	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	8.88e-05	0.000967	CbGpPWpGaD
Testosterone Propionate—Pruritus—Doxorubicin—kidney cancer	8.84e-05	0.000341	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MYC—kidney cancer	8.68e-05	0.000946	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	8.66e-05	0.000943	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CRABP1—kidney cancer	8.61e-05	0.000938	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GPC3—kidney cancer	8.59e-05	0.000936	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Doxorubicin—kidney cancer	8.55e-05	0.00033	CcSEcCtD
Testosterone Propionate—Testosterone—ABCB1—kidney cancer	8.52e-05	0.028	CrCbGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	8.49e-05	0.000925	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ITPR2—kidney cancer	8.36e-05	0.000911	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CA2—kidney cancer	8.36e-05	0.000911	CbGpPWpGaD
Testosterone Propionate—Dizziness—Doxorubicin—kidney cancer	8.27e-05	0.000319	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—ALAD—kidney cancer	8.15e-05	0.000887	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—KRAS—kidney cancer	8.02e-05	0.000874	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—RPL14—kidney cancer	8.02e-05	0.000873	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ITPR2—kidney cancer	8.01e-05	0.000872	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ST3GAL2—kidney cancer	7.95e-05	0.000866	CbGpPWpGaD
Testosterone Propionate—Vomiting—Doxorubicin—kidney cancer	7.95e-05	0.000306	CcSEcCtD
Testosterone Propionate—Rash—Doxorubicin—kidney cancer	7.88e-05	0.000304	CcSEcCtD
Testosterone Propionate—Dermatitis—Doxorubicin—kidney cancer	7.87e-05	0.000303	CcSEcCtD
Testosterone Propionate—Headache—Doxorubicin—kidney cancer	7.83e-05	0.000302	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	7.82e-05	0.000852	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ALDH1A1—kidney cancer	7.77e-05	0.000847	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—MAPK1—kidney cancer	7.71e-05	0.00084	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ACHE—kidney cancer	7.62e-05	0.00083	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTT1—kidney cancer	7.62e-05	0.00083	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PGK1—kidney cancer	7.45e-05	0.000812	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SLC5A3—kidney cancer	7.45e-05	0.000812	CbGpPWpGaD
Testosterone Propionate—Nausea—Doxorubicin—kidney cancer	7.42e-05	0.000286	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	7.4e-05	0.000806	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.38e-05	0.000804	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—LDHB—kidney cancer	7.31e-05	0.000796	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ACHE—kidney cancer	7.3e-05	0.000795	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTT1—kidney cancer	7.3e-05	0.000795	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SCARB1—kidney cancer	7.22e-05	0.000786	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	7.19e-05	0.000784	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTGS1—kidney cancer	7.14e-05	0.000778	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—kidney cancer	7.13e-05	0.000777	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	7.04e-05	0.000767	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PSMD7—kidney cancer	7.01e-05	0.000763	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SCARB1—kidney cancer	6.91e-05	0.000753	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTGS1—kidney cancer	6.84e-05	0.000745	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PSMD7—kidney cancer	6.71e-05	0.000731	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	6.65e-05	0.000724	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—BCHE—kidney cancer	6.64e-05	0.000723	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SLC5A5—kidney cancer	6.56e-05	0.000715	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—EIF4EBP1—kidney cancer	6.54e-05	0.000712	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—HSPB1—kidney cancer	6.54e-05	0.000712	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—BCHE—kidney cancer	6.36e-05	0.000693	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SLC2A1—kidney cancer	6.34e-05	0.00069	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CA9—kidney cancer	6.34e-05	0.00069	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SLC5A5—kidney cancer	6.28e-05	0.000684	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.11e-05	0.000665	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PSMD7—kidney cancer	6.08e-05	0.000662	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SLC2A1—kidney cancer	6.07e-05	0.000661	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	5.91e-05	0.000643	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.89e-05	0.000641	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—JUNB—kidney cancer	5.45e-05	0.000594	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CRABP1—kidney cancer	5.39e-05	0.000587	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTP1—kidney cancer	5.28e-05	0.000576	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.13e-05	0.000559	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTP1—kidney cancer	5.06e-05	0.000551	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ITPR2—kidney cancer	5.01e-05	0.000546	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ABCB1—kidney cancer	5e-05	0.000545	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTM1—kidney cancer	4.86e-05	0.000529	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ABCB1—kidney cancer	4.79e-05	0.000522	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTM1—kidney cancer	4.65e-05	0.000507	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP1A1—kidney cancer	4.6e-05	0.000501	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTT1—kidney cancer	4.57e-05	0.000497	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ACHE—kidney cancer	4.57e-05	0.000497	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—CDKN2B—kidney cancer	4.44e-05	0.000484	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP1A1—kidney cancer	4.41e-05	0.00048	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SCARB1—kidney cancer	4.32e-05	0.000471	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTGS1—kidney cancer	4.28e-05	0.000466	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PSMD7—kidney cancer	4.2e-05	0.000457	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—BCHE—kidney cancer	3.98e-05	0.000433	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SLC5A5—kidney cancer	3.93e-05	0.000428	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SLC2A1—kidney cancer	3.8e-05	0.000413	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.62e-05	0.000394	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—MYC—kidney cancer	3.57e-05	0.000389	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—POMC—kidney cancer	3.43e-05	0.000374	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—POMC—kidney cancer	3.29e-05	0.000358	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTP1—kidney cancer	3.17e-05	0.000345	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ABCB1—kidney cancer	3e-05	0.000326	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTM1—kidney cancer	2.91e-05	0.000317	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP1A1—kidney cancer	2.76e-05	0.0003	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTGS2—kidney cancer	2.74e-05	0.000298	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTGS2—kidney cancer	2.62e-05	0.000286	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTEN—kidney cancer	2.39e-05	0.00026	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTEN—kidney cancer	2.29e-05	0.000249	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—POMC—kidney cancer	2.06e-05	0.000224	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MAPK3—kidney cancer	1.77e-05	0.000193	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MYC—kidney cancer	1.72e-05	0.000187	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CA—kidney cancer	1.68e-05	0.000183	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTGS2—kidney cancer	1.64e-05	0.000179	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CA—kidney cancer	1.61e-05	0.000176	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTEN—kidney cancer	1.43e-05	0.000156	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CA—kidney cancer	1.01e-05	0.00011	CbGpPWpGaD
